INTERNATIONAL PATENT: PRELUDE THERAPEUTICS INCORPORATED, FULTANG, NORMAN, BHAGWAT, NEHA, SCHERLE, PEGGY FILES APPLICATION FOR "CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS"

GENEVA, Sept. 18 -- PRELUDE THERAPEUTICS INCORPORATED (175 Innovation BoulevardWilmington, Delaware 19805), FULTANG, Norman (175 Innovation BoulevardWilmington, Delaware 19805), BHAGWAT, Neha (175 Innovation BoulevardWilmington, Delaware 19805), SCHERLE, Peggy (175 Innovation BoulevardWilmington, Delaware 19805) filed a patent application (PCT/US2025/018942) for "CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS" on Mar 07, 2025. With publication no. WO/2025/189114, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VADDI, Kri...